EBS Emergent BioSolutions Inc. Common Stock
EBS Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
EBS Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
EBS Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
- Achat fort 1 16,7%
- Achat 4 66,7%
- Conserver 1 16,7%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
2 analystes · 2026-08-17Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 30 juin 2026 | $0.60 | $0.11 | 0.49% |
| 31 mars 2026 | $0.21 | $-0.25 | 0.46% |
| 31 décembre 2025 | $-0.43 | $0.11 | -0.54% |
| 30 septembre 2025 | $1.06 | $-0.12 | 1.2% |
| 30 juin 2025 | $0.16 | $-0.49 | 0.65% |
| 31 mars 2025 | $0.71 | $0.44 | 0.27% |
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| EBS | $644M | 13.3 | -28.8% | 7.1% | 9.9% | — |
| RCEL | $105M | -2.0 | 11.5% | -67.8% | 328.9% | 82.1% |
| TARA | $286M | -4.0 | — | — | -33.7% | — |
| AKBA | $427M | -80.5 | 47.5% | -2.3% | -17.3% | — |
| ALEC | $172M | -1.1 | -79.1% | -679.2% | -280.7% | — |
| ARCT | $174M | -2.6 | -46.1% | -80.2% | -29.6% | — |
| NBP | — | — | — | — | — | — |
| IMUX | — | -0.9 | — | — | — | — |
| ORGO | $658M | 34.5 | 17.0% | 6.6% | 13.9% | — |
| RNA | $10.91B | -14.5 | 72.1% | -3650.4% | -47.5% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 18
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $743M | $1.04B | $1.05B | $1.12B | $1.77B | $1.58B | $1.11B | $782M | $561M | $489M | $489M | $404M | |
| Cost of Revenue | $326M | $681M | $705M | $693M | $748M | $537M | $434M | $322M | $188M | $126M | $107M | $102M | |
| Gross Profit | · | · | $318M | $383M | $891M | $925M | · | · | · | · | · | · | |
| R&D Expense | $53M | $71M | $111M | $188M | $235M | $238M | $226M | $143M | $97M | $107M | $119M | $105M | |
| SG&A Expense | $186M | $308M | $368M | $340M | $349M | $304M | $274M | $202M | $143M | $143M | $121M | $109M | |
| Operating Expenses | · | · | · | · | · | · | $992M | $693M | $437M | $383M | · | · | |
| Operating Income | $100M | $-109M | $-726M | $-170M | $341M | $438M | $114M | $90M | $124M | $106M | $142M | $89M | |
| Interest Expense | · | · | $88M | $37M | $34M | $31M | $38M | $10M | $7M | $8M | $7M | $8M | |
| Interest Income | · | · | · | · | · | · | · | · | $2M | $1M | $572.0K | $320.0K | |
| Other Non-op | $54M | $12M | $6M | $-12M | $-4M | $5M | $2M | $2M | $900.0K | $1M | $153.0K | $3M | |
| Pretax Income | $83M | $-143M | $-731M | $-219M | $303M | $412M | $77M | $82M | $119M | $99M | $136M | $84M | |
| Income Tax | $30M | $48M | $29M | $-7M | $84M | $106M | $23M | $19M | $36M | $37M | $44M | $30M | |
| Net Income | $53M | $-191M | $-760M | $-212M | $220M | $306M | $54M | $63M | $83M | $52M | $63M | $37M | |
| EPS (Basic) | $0.98 | $-3.60 | $-14.85 | $-4.22 | $4.10 | $5.80 | $1.06 | $1.25 | $1.98 | $1.29 | $1.63 | $0.98 | |
| EPS (Diluted) | $0.93 | $-3.60 | $-14.85 | $-4.22 | $4.06 | $5.68 | $1.04 | $1.22 | $1.71 | $1.13 | $1.41 | $0.88 | |
| Shares (Basic) | 53,500,000 | 53,000,000 | 51,200,000 | 50,100,000 | 53,500,000 | 52,700,000 | 51,500,000 | 50,100,000 | 41,800,000 | 40,200,000 | 38,595,435 | 37,344,891 | |
| Shares (Diluted) | 56,700,000 | 53,000,000 | 51,200,000 | 50,100,000 | 54,100,000 | 53,800,000 | 52,400,000 | 51,400,000 | 50,300,000 | 49,300,000 | 47,255,842 | 45,802,807 | |
| EBITDA | $196M | $100.0K | $-601M | $-170M | $353M | $484M | $164M | $126M | $157M | $134M | $121M | $81M |
Bilan 30
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $205M | $100M | $112M | $643M | $576M | $621M | $168M | $112M | $178M | $272M | $313M | $280M | |
| Receivables | $84M | $154M | $191M | $159M | $279M | $231M | $271M | $262M | $144M | $138M | $114M | $59M | |
| Inventory | $343M | $312M | $329M | $351M | $344M | $307M | $222M | $206M | $143M | $74M | $61M | $66M | |
| Prepaid Expense | $26M | $27M | $48M | $58M | $70M | $36M | $25M | $32M | $17M | $16M | $18M | $24M | |
| Current Assets | $662M | $599M | $680M | $1.21B | $1.27B | $1.20B | $686M | $621M | $485M | $510M | $537M | $432M | |
| PP&E (Net) | $205M | $271M | $383M | $818M | $800M | $644M | $542M | $510M | $407M | $376M | $328M | $314M | |
| PP&E (Gross) | $510M | $668M | $794M | $1.20B | $1.12B | $903M | $753M | $682M | $540M | $488M | $422M | $393M | |
| Accum. Depreciation | $304M | $397M | $411M | $384M | $319M | $259M | $210M | $172M | $132M | $112M | $94M | $79M | |
| Goodwill | $0 | $0 | $0 | $218M | $225M | $267M | $267M | $260M | $49M | $41M | $41M | $53M | |
| Intangibles | $436M | $502M | $567M | $729M | $605M | $663M | $713M | $762M | $120M | $34M | $41M | $58M | |
| Other Non-current Assets | $14M | $19M | $194M | $191M | $58M | $113M | $90M | $14M | $6M | $2M | $2M | $8M | |
| Total Assets | $1.32B | $1.39B | $1.82B | $3.17B | $2.96B | $2.88B | $2.33B | $2.23B | $1.07B | $970M | $1.04B | $939M | |
| Accounts Payable | $56M | $61M | $112M | $104M | $129M | $136M | $95M | $81M | $42M | $35M | $38M | $41M | |
| Accrued Liabilities | $12M | $18M | $19M | $35M | $52M | $47M | $40M | $31M | $5M | $6M | $6M | $6M | |
| Short-term Debt | · | $0 | $414M | $957M | $32M | $34M | $13M | $10M | $0 | $20M | $0 | · | |
| Current Liabilities | $132M | $162M | $651M | $1.23B | $374M | $384M | $216M | $200M | $100M | $106M | $100M | $93M | |
| Capital Leases | $9M | $10M | $14M | $15M | $24M | $28M | $22M | · | · | · | · | · | |
| Deferred Tax | $38M | $42M | $47M | $60M | $93M | $53M | $64M | $68M | $0 | · | · | · | |
| Other Non-current Liabilities | $54M | $39M | $29M | $42M | $70M | $68M | $49M | $49M | $5M | $2M | $1M | $1M | |
| Total Liabilities | $796M | $907M | $1.17B | $1.78B | $1.35B | $1.44B | $1.24B | $1.22B | $158M | $374M | $377M | $385M | |
| Long-term Debt | $590M | $700M | $868M | $1.41B | $850M | $886M | $822M | $809M | $14M | · | · | · | |
| Total Debt | $572M | $664M | $1.27B | · | $873M | $909M | $824M | $805M | $13M | $268M | $253M | $251M | |
| Common Stock | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $41.0K | $40.0K | $38.0K | |
| Paid-in Capital | $942M | $928M | $904M | $874M | $829M | $785M | $716M | $689M | $618M | $352M | $318M | $274M | |
| Retained Earnings | $-160M | $-212M | $-22M | $739M | $950M | $727M | $422M | $367M | $337M | $254M | $351M | $288M | |
| Treasury Stock | $253M | $228M | $228M | $228M | $152M | $40M | $40M | $40M | $40M | $6M | $6M | $6M | |
| AOCI | $-8M | $-5M | $-6M | $3M | $-16M | $-25M | $-10M | $-6M | $-4M | $-4M | $-3M | $-3M | |
| Stockholders' Equity | $523M | $483M | $649M | $1.39B | $1.61B | $1.45B | $1.09B | $1.01B | $912M | $596M | $660M | $553M | |
| Liabilities + Equity | $1.32B | $1.39B | $1.82B | $3.17B | $2.96B | $2.88B | $2.33B | $2.23B | $1.07B | $970M | $1.04B | $939M | |
| Shares Outstanding | 52,100,000 | 54,300,000 | 52,200,000 | 50,100,000 | 51,300,000 | 54,300,000 | 51,700,000 | 51,200,000 | 49,400,000 | 41,000,000 | 39,800,000 | 38,129,872 |
Flux de trésorerie 19
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $96M | $109M | $125M | $143M | $124M | $50M | $50M | $36M | $32M | $28M | $24M | $22M | |
| Stock-based Comp | $16M | $18M | $23M | $45M | $42M | $52M | $27M | $23M | $15M | $18M | $16M | $13M | |
| Deferred Tax | $-4M | $-6M | $-7M | $-34M | $43M | $-3M | $-1M | $9M | $3M | $5M | $3M | $16M | |
| Amort. of Intangibles | $65M | $65M | $66M | $60M | $58M | $60M | $59M | $25M | $9M | $7M | $7M | $7M | |
| Restructuring | $-2M | $22M | $29M | · | · | · | · | · | · | · | · | $0 | |
| Other Non-cash | $10M | $128M | $413M | · | · | $132M | $58M | $-89M | $75M | $-50M | $-62M | $23M | |
| Operating Cash Flow | $171M | $59M | $-206M | $-34M | $320M | $537M | $188M | $42M | $208M | $55M | $43M | $112M | |
| CapEx | $14M | $23M | $52M | $116M | $224M | $142M | $87M | $72M | $55M | $76M | $45M | $31M | |
| Investing Cash Flow | $69M | $125M | $212M | $-381M | $-224M | $-152M | $-97M | $-897M | $-250M | $-76M | $-45M | $-210M | |
| Debt Issued | · | · | · | · | · | · | · | $798M | $0 | $0 | $2M | $1M | |
| Net Debt Issued | · | · | · | · | · | · | · | $795M | $0 | $0 | $0 | $-62M | |
| Stock Issued | $0 | $0 | $8M | $0 | $0 | · | · | · | · | · | · | · | |
| Stock Repurchased | $25M | $0 | $0 | $82M | $106M | $0 | $0 | $100.0K | $33M | $0 | $100.0K | $200.0K | |
| Net Stock Activity | $-25M | $0 | $8M | $-82M | $-106M | $0 | $0 | $-100.0K | $-33M | $0 | $-100.0K | $-200.0K | |
| Financing Cash Flow | $-137M | $-190M | $-536M | $481M | $-141M | $70M | $-36M | $789M | $-51M | $-20M | $35M | $199M | |
| Net Change in Cash | $104M | $-6M | $-531M | $66M | $-45M | $454M | $56M | $-67M | $-93M | $-41M | $32M | $101M | |
| Taxes Paid | $40M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $157M | $36M | $-258M | $-150M | $96M | $395M | $101M | $-30M | $153M | $-23M | $-353.0K | $82M | |
| Levered FCF | · | · | $-349M | $-186M | $71M | $372M | $74M | $-38M | $149M | $-28M | $-5M | $76M |
Rentabilité 8
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | 30.3% | 34.3% | · | · | · | · | · | · | · | · | |
| Operating Margin | 13.5% | -10.4% | -69.2% | -15.2% | 19.7% | 27.9% | 10.3% | 11.5% | 22.2% | 21.6% | 18.4% | 12.9% | |
| Net Margin | 7.1% | -18.3% | -72.5% | -18.9% | 12.9% | 19.6% | 4.9% | 8.0% | 14.7% | 10.6% | 12.0% | 8.2% | |
| Pretax Margin | 11.2% | -13.7% | -69.7% | -19.6% | 17.5% | 26.2% | 7.0% | 10.4% | 21.1% | 20.3% | 17.2% | 11.8% | |
| EBITDA Margin | 26.4% | 0.01% | -57.3% | -15.2% | 19.7% | 31.1% | 14.8% | 16.1% | 27.9% | 27.3% | 23.1% | 18.0% | |
| ROA | 3.9% | -11.9% | -30.5% | · | 7.9% | 11.7% | 2.4% | 3.8% | 8.1% | 5.2% | 6.4% | 4.7% | |
| ROE | 9.9% | -38.5% | -113.0% | · | 14.7% | 22.6% | 5.1% | 6.3% | 10.9% | 8.2% | 10.4% | 7.0% | |
| ROIC | 5.8% | -12.7% | -39.3% | · | 10.4% | 13.8% | 4.2% | 3.8% | 9.3% | 7.7% | 7.4% | 5.0% |
Liquidité et Solvabilité 5
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.0 | 3.7 | 1.0 | · | 3.4 | 3.1 | 3.2 | 3.1 | 4.9 | 4.8 | 5.4 | 4.7 | |
| Quick Ratio | 2.2 | 1.6 | 0.5 | · | 2.3 | 2.2 | 2.0 | 1.9 | 3.2 | 3.9 | 4.4 | 3.7 | |
| Debt / Equity | 1.1 | 1.4 | 2.0 | · | 0.5 | 0.6 | 0.8 | 0.8 | 0.0 | 0.4 | 0.4 | 0.5 | |
| LT Debt / Equity | 1.1 | 1.4 | 0.7 | · | 0.5 | 0.6 | 0.7 | 0.8 | 0.0 | 0.4 | 0.4 | 0.5 | |
| Interest Coverage | · | · | -8.3 | -4.6 | 10.2 | 13.9 | 3.0 | 9.1 | 18.9 | 13.9 | 14.7 | 7.0 |
Efficacité 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.6 | 0.4 | · | 0.6 | 0.6 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | |
| Inventory Turnover | 1.0 | · | 2.1 | · | · | 2.0 | 2.0 | 1.8 | 1.8 | 1.9 | 1.7 | 2.9 | |
| Receivables Turnover | 6.2 | 6.0 | 6.0 | · | 7.1 | 6.2 | 4.1 | 3.9 | 4.0 | 3.9 | 5.8 | 7.5 |
Taux de croissance 7
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -28.8% | -0.54% | -6.1% | -37.0% | 12.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -12.7% | -16.2% | -12.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -14.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | · | · | -28.5% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -30.4% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | · | · | -28.2% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -29.7% | · | · | · | · | · | · | · | · | · | · | · |
Valorisation (TTM) 14
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $743M | $1.04B | $1.05B | $1.12B | $1.77B | $1.58B | $1.11B | $782M | $561M | $489M | $489M | $404M | |
| Net Income TTM | $53M | $-191M | $-760M | $-212M | $220M | $306M | $54M | $63M | $83M | $52M | $63M | $37M | |
| Market Cap | $644M | $519M | $125M | · | $2.23B | $4.76B | $2.79B | $3.04B | $2.30B | $1.33B | $1.58B | $1.03B | |
| Enterprise Value | $1.01B | $1.08B | $1.29B | · | $2.53B | $5.05B | $3.45B | $3.73B | $2.13B | $1.33B | $1.52B | $997M | |
| P/E | 13.3 | -2.7 | -0.2 | -2.8 | 10.7 | 15.8 | 51.9 | 48.6 | 27.2 | 29.1 | 28.4 | 30.9 | |
| P/S | 0.9 | 0.5 | 0.1 | · | 1.3 | 3.0 | 2.5 | 3.9 | 4.1 | 2.7 | 3.2 | 2.5 | |
| P/B | 1.2 | 1.1 | 0.2 | · | 1.4 | 3.3 | 2.6 | 3.0 | 2.5 | 2.2 | 2.4 | 1.9 | |
| P / Tangible Book | 7.5 | · | 1.5 | 1.3 | 2.9 | 9.1 | · | · | · | · | · | · | |
| P / Cash Flow | 3.8 | 8.8 | -0.6 | · | 6.9 | 8.9 | 14.8 | 72.6 | 11.0 | 24.9 | 35.5 | 9.1 | |
| P / FCF | 4.1 | 14.5 | -0.5 | · | 23.2 | 12.0 | 27.6 | -100.2 | 15.0 | -58.5 | -4466.5 | 12.6 | |
| EV / EBITDA | 5.2 | 10833.1 | -2.1 | · | 7.2 | 10.4 | 21.1 | 29.6 | 13.6 | 10.0 | 12.6 | 12.3 | |
| EV / FCF | 6.4 | 30.3 | -5.0 | · | 26.3 | 12.8 | 34.1 | -123.0 | 13.9 | -58.4 | -4297.1 | 12.2 | |
| EV / Revenue | 1.4 | 1.0 | 1.2 | · | 1.4 | 3.2 | 3.1 | 4.8 | 3.8 | 2.7 | 3.1 | 2.5 | |
| Earnings Yield | 7.5% | -37.7% | -618.8% | -35.7% | 9.3% | 6.3% | 1.9% | 2.1% | 3.7% | 3.4% | 3.5% | 3.2% |
Compte de résultat 16
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $234M | $156M | $149M | $231M | $141M | $222M | $195M | $294M | $255M | $300M | $277M | $270M | $338M | $164M | $330M | $240M | |
| Cost of Revenue | $97M | $72M | $85M | $86M | $67M | $88M | $118M | $123M | $296M | $145M | $185M | $177M | $191M | $153M | · | $147M | |
| Gross Profit | · | · | · | · | · | · | · | $161M | $-48M | $148M | · | $87M | $141M | $5M | · | $75M | |
| R&D Expense | $9M | $10M | $12M | $14M | $12M | $15M | $9M | $14M | $33M | $15M | $29M | $15M | $26M | $41M | $50M | $42M | |
| SG&A Expense | $45M | $47M | $51M | $39M | $44M | $52M | $61M | $77M | $86M | $85M | $90M | $86M | $91M | $101M | $92M | $82M | |
| Operating Income | $-125M | $10M | $-28M | $76M | $2M | $50M | $-10M | $64M | $-204M | $40M | $-44M | $-242M | $-293M | $-148M | $-55M | $-45M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $24M | · | $20M | $29M | $18M | · | $8M | |
| Other Non-op | $0 | $14M | $-8M | $-4M | $-4M | $70M | $-4M | $22M | $-3M | $-3M | $8M | $-3M | $-4M | $5M | $7M | $-13M | |
| Pretax Income | $-166M | $13M | $-51M | $58M | $-17M | $93M | $-28M | $142M | $-270M | $12M | $-54M | $-266M | $-250M | $-161M | $-65M | $-67M | |
| Income Tax | $14M | $7M | $4M | $6M | $-5M | $25M | $4M | $28M | $13M | $3M | $-5M | $-2M | $11M | $26M | $-800.0K | $20M | |
| Net Income | $-180M | $7M | $-55M | $51M | $-12M | $68M | $-31M | $115M | $-283M | $9M | $-50M | $-263M | $-261M | $-186M | $-67M | $-87M | |
| EPS (Basic) | $-3.49 | $0.13 | $-1.01 | $0.96 | $-0.22 | $1.25 | $-0.55 | $2.16 | $-5.38 | $0.17 | $-0.90 | $-5.08 | $-5.16 | $-3.71 | $-1.32 | $-1.75 | |
| EPS (Diluted) | $-3.49 | $0.07 | $-0.95 | $0.91 | $-0.22 | $1.19 | $-0.45 | $2.06 | $-5.38 | $0.17 | $-0.90 | $-5.08 | $-5.16 | $-3.71 | $-1.32 | $-1.75 | |
| Shares (Basic) | 51,600,000 | 51,900,000 | -108,300,000 | 53,200,000 | 54,200,000 | 54,400,000 | -104,900,000 | 53,100,000 | 52,600,000 | 52,200,000 | -101,500,000 | 51,800,000 | 50,700,000 | 50,200,000 | -100,500,000 | 49,900,000 | |
| Shares (Diluted) | 51,600,000 | 56,500,000 | -111,300,000 | 56,500,000 | 54,200,000 | 57,300,000 | -107,400,000 | 55,600,000 | 52,600,000 | 52,200,000 | -101,500,000 | 51,800,000 | 50,700,000 | 50,200,000 | -100,500,000 | 49,900,000 | |
| EBITDA | $-125M | $34M | · | $76M | $2M | $75M | · | $64M | $-204M | $68M | · | $-242M | $-293M | $-114M | · | $-42M |
Bilan 30
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $140M | $160M | $205M | $246M | $267M | $149M | $100M | $150M | $70M | $78M | $112M | $88M | $89M | $430M | $643M | $241M | |
| Receivables | $190M | $122M | $84M | $150M | $80M | $204M | $154M | $121M | $196M | $234M | · | $216M | $290M | $156M | · | $191M | |
| Inventory | $304M | $328M | $343M | $356M | $339M | $314M | $312M | $323M | $318M | $333M | · | $354M | $354M | $368M | · | $546M | |
| Prepaid Expense | $25M | $27M | $26M | $26M | $24M | $30M | $27M | $61M | $36M | $36M | · | $62M | $45M | $42M | · | $140M | |
| Current Assets | $666M | $638M | $662M | $787M | $720M | $707M | $599M | $661M | $654M | $682M | · | $721M | $778M | $1.22B | · | $1.12B | |
| PP&E (Net) | $178M | $199M | $205M | $210M | $216M | $221M | $271M | $278M | $306M | $379M | · | $395M | $396M | $717M | · | $807M | |
| PP&E (Gross) | $475M | $509M | $510M | $500M | $516M | $518M | $668M | $672M | $707M | $802M | · | $796M | $787M | $1.09B | · | $1.17B | |
| Accum. Depreciation | $297M | $310M | $304M | $291M | $300M | $297M | $397M | $394M | $401M | $423M | · | $401M | $391M | $375M | · | $366M | |
| Goodwill | · | · | $0 | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $218M | $218M | · | $225M | |
| Intangibles | $262M | $470M | $436M | $453M | $469M | $485M | $502M | $518M | $534M | $550M | · | $583M | $593M | $609M | · | $723M | |
| Other Non-current Assets | $11M | $13M | $14M | $12M | $12M | $13M | $19M | $20M | $19M | $191M | · | $194M | $195M | $185M | · | $36M | |
| Total Assets | $1.12B | $1.32B | $1.32B | $1.46B | $1.42B | $1.43B | $1.39B | $1.48B | $1.51B | $1.80B | · | $1.89B | $2.18B | $2.95B | · | $2.91B | |
| Accounts Payable | $50M | $40M | $56M | $57M | $64M | $58M | $61M | $82M | $96M | $100M | · | $113M | $108M | $124M | · | $104M | |
| Accrued Liabilities | $17M | $9M | $12M | $14M | $14M | $13M | $18M | $16M | $17M | $14M | · | $17M | $31M | $21M | · | $36M | |
| Short-term Debt | · | · | · | · | · | · | · | $800.0K | $415M | $459M | · | $414M | $455M | $951M | · | $21M | |
| Current Liabilities | $123M | $149M | $132M | $136M | $127M | $112M | $162M | $230M | $620M | $630M | · | $664M | $693M | $1.22B | · | $268M | |
| Capital Leases | $5M | $9M | $9M | $6M | $6M | $5M | $10M | $11M | $12M | $13M | · | $15M | $13M | $13M | · | $16M | |
| Deferred Tax | $35M | $33M | $38M | $36M | $46M | $60M | $42M | $42M | $35M | $35M | · | $52M | $58M | $60M | · | $114M | |
| Other Non-current Liabilities | $35M | $42M | $54M | $43M | $40M | $35M | $39M | $36M | $26M | $28M | · | $31M | $23M | $24M | · | $45M | |
| Total Liabilities | $775M | $797M | $796M | $878M | $881M | $873M | $907M | $969M | $1.13B | $1.14B | · | $1.20B | $1.22B | $1.75B | · | $1.46B | |
| Long-term Debt | $590M | $590M | $590M | $693M | $700M | $700M | $700M | $701M | $864M | $909M | · | $866M | $909M | $1.41B | · | $1.06B | |
| Total Debt | $582M | $574M | · | $663M | $668M | $666M | · | $663M | $1.28B | $1.37B | · | $1.28B | $1.36B | $2.35B | · | $1.07B | |
| Common Stock | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | · | $100.0K | $100.0K | $100.0K | · | $100.0K | |
| Paid-in Capital | $952M | $944M | $942M | $939M | $935M | $931M | $928M | $924M | $915M | $910M | · | $900M | $896M | $878M | · | $860M | |
| Retained Earnings | $-333M | $-153M | $-160M | $-105M | $-156M | $-144M | $-212M | $-181M | $-296M | $-13M | · | $28M | $290M | $551M | · | $822M | |
| Treasury Stock | $270M | $262M | $253M | $244M | $235M | $228M | $228M | $228M | $228M | $228M | · | $228M | $228M | $228M | · | $228M | |
| AOCI | $-7M | $-7M | $-8M | $-8M | $-8M | $-6M | $-5M | $-7M | $-6M | $-6M | · | $-3M | $-2M | $1M | · | $-5M | |
| Stockholders' Equity | $341M | $523M | $523M | $582M | $536M | $553M | $483M | $508M | $386M | $664M | $649M | $697M | $956M | $1.20B | $1.39B | $1.45B | |
| Liabilities + Equity | $1.12B | $1.32B | $1.32B | $1.46B | $1.42B | $1.43B | $1.39B | $1.48B | $1.51B | $1.80B | · | $1.89B | $2.18B | $2.95B | · | $2.91B | |
| Shares Outstanding | 51,300,000 | 51,800,000 | 52,100,000 | 52,700,000 | 53,700,000 | 54,500,000 | 54,300,000 | 54,100,000 | 52,900,000 | 52,400,000 | · | 51,800,000 | 51,800,000 | 50,400,000 | · | 49,900,000 |
Flux de trésorerie 16
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $24M | $24M | $24M | $23M | $24M | $25M | $26M | $26M | $28M | $28M | $30M | $28M | $33M | $35M | $36M | $32M | |
| Stock-based Comp | $7M | $2M | $5M | $5M | $5M | $2M | $4M | $2M | $6M | $6M | $4M | $4M | $8M | $7M | $12M | $11M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-57M | $20M | |
| Amort. of Intangibles | $17M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $17M | $18M | $14M | |
| Restructuring | · | · | $0 | $300.0K | $-1M | $-1M | $-400.0K | $6M | $17M | $-500.0K | $-600.0K | $20M | $-100.0K | $10M | · | · | |
| Other Non-cash | · | $-66M | · | · | · | $-106M | · | · | · | $-105M | · | · | · | $-42M | · | · | |
| Operating Cash Flow | $56M | $-34M | $78M | $-2M | $106M | $-11M | $-80M | $154M | $48M | $-63M | $32M | $60M | $-114M | $-184M | $93M | $-74M | |
| CapEx | $2M | $2M | $4M | $3M | $3M | $4M | $2M | $6M | $5M | $11M | $11M | $13M | $12M | $15M | $24M | $28M | |
| Investing Cash Flow | $-52M | $-2M | $-4M | $-3M | $17M | $60M | $29M | $112M | $-5M | $-11M | $-11M | $-19M | $258M | $-15M | $-45M | $-272M | |
| Stock Issued | · | $400.0K | $-1M | · | · | $0 | $0 | $0 | · | · | $200.0K | $0 | · | · | $0 | $0 | |
| Stock Repurchased | $9M | $9M | $9M | $9M | $7M | $0 | $0 | $0 | · | · | $0 | $0 | $0 | $0 | $200.0K | $0 | |
| Net Stock Activity | · | $-9M | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Financing Cash Flow | $-24M | $-11M | $-114M | $-16M | $-6M | $-400.0K | $500.0K | $-180M | $-51M | $41M | $5M | $-43M | $-487M | $-10M | $353M | $229M | |
| Net Change in Cash | $-21M | $-48M | $-40M | $-22M | $118M | $47M | $-51M | $85M | $-8M | $-33M | $24M | $-800.0K | $-344M | $-210M | $402M | $-117M | |
| Free Cash Flow | · | $-36M | · | · | · | $-15M | · | · | · | $-73M | · | · | · | $-199M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-91M | · | · | · | $-219M | · | · |
Rentabilité 8
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | 54.9% | -18.9% | 49.2% | · | 32.2% | 41.6% | 2.1% | · | 30.8% | |
| Operating Margin | -53.4% | 6.7% | · | 33.1% | 1.1% | 22.5% | · | 21.9% | -79.9% | 13.2% | · | -89.5% | -86.7% | -89.7% | · | -17.5% | |
| Net Margin | -76.9% | 4.4% | · | 22.1% | -8.5% | 30.6% | · | 39.1% | -111.1% | 3.0% | · | -97.4% | -77.3% | -110.8% | · | -31.5% | |
| Pretax Margin | -71.0% | 8.6% | · | 24.9% | -11.9% | 41.7% | · | 48.5% | -105.9% | 4.0% | · | -98.3% | -74.1% | -97.6% | · | -26.6% | |
| EBITDA Margin | -53.4% | 21.8% | · | 33.1% | 1.1% | 33.9% | · | 21.9% | -79.9% | 22.5% | · | -89.5% | -86.7% | -68.8% | · | -17.5% | |
| ROA | -14.2% | 0.50% | · | 3.5% | -0.82% | 4.2% | · | 6.8% | -15.3% | 0.38% | · | -11.0% | -10.6% | -6.4% | · | -2.6% | |
| ROE | -41.1% | 1.3% | · | 9.4% | -2.6% | 11.2% | · | 19.0% | -42.2% | 0.96% | · | -24.5% | -21.2% | -13.2% | · | -5.1% | |
| ROIC | -14.7% | 0.49% | · | 5.5% | 0.09% | 3.0% | · | 4.4% | -12.8% | 1.5% | · | -12.2% | -13.2% | -4.7% | · | -2.0% |
Liquidité et Solvabilité 5
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.4 | 4.3 | · | 5.8 | 5.7 | 6.3 | · | 2.9 | 1.1 | 1.1 | · | 1.1 | 1.1 | 1.0 | · | 4.2 | |
| Quick Ratio | 2.7 | 1.9 | · | 2.9 | 2.7 | 3.2 | · | 1.2 | 0.4 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 1.6 | |
| Debt / Equity | 1.7 | 1.1 | · | 1.1 | 1.2 | 1.2 | · | 1.3 | 3.3 | 2.1 | · | 1.8 | 1.4 | 2.0 | · | 0.7 | |
| LT Debt / Equity | 1.7 | 1.1 | · | 1.1 | 1.2 | 1.2 | · | 1.3 | 1.2 | 0.7 | · | 0.6 | 0.5 | 0.4 | · | 0.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 1.6 | · | -12.3 | -10.2 | -8.3 | · | -4.9 |
Efficacité 3
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.3 | 0.2 | · | 0.3 | 0.2 | 0.3 | · | 0.4 | 0.9 | 0.4 | · | 0.4 | 0.5 | 0.4 | · | · | |
| Receivables Turnover | 1.7 | 1.0 | · | 1.7 | 1.0 | 1.0 | · | 1.7 | 1.0 | 1.5 | · | 1.3 | 1.5 | 1.0 | · | 1.1 |
Valorisation (TTM) 14
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $762M | $750M | · | $888M | $912M | $1.07B | · | $1.12B | $1.16B | $1.07B | · | $1.10B | $1.07B | $977M | · | $1.52B | |
| Net Income TTM | $-134M | $114M | · | $222M | $-112M | $-91M | · | $-423M | $-799M | $-702M | · | $-778M | $-602M | $-393M | · | $48M | |
| Market Cap | $430M | $430M | · | $465M | $343M | $265M | · | $452M | $361M | $133M | · | $176M | $381M | $522M | · | $1.05B | |
| Enterprise Value | $872M | $843M | · | $882M | $743M | $781M | · | $965M | $1.57B | $1.42B | · | $1.36B | $1.65B | $2.44B | · | $1.88B | |
| P/E | -3.1 | 4.3 | · | 2.2 | -2.7 | -2.5 | · | -1.0 | -0.4 | -0.2 | · | -0.2 | -0.6 | -1.3 | · | 30.0 | |
| P/S | 0.6 | 0.6 | · | 0.5 | 0.4 | 0.2 | · | 0.4 | 0.3 | 0.1 | · | 0.2 | 0.4 | 0.5 | · | 0.7 | |
| P/B | 1.3 | 0.8 | · | 0.8 | 0.6 | 0.5 | · | 0.9 | 0.9 | 0.2 | · | 0.3 | 0.4 | 0.4 | · | 0.7 | |
| P / Tangible Book | 5.4 | 8.2 | · | 3.6 | 5.1 | 3.9 | · | · | · | 1.2 | · | 1.5 | 2.6 | 1.4 | · | 2.1 | |
| P / Cash Flow | · | -12.7 | · | · | · | -23.6 | · | · | · | -2.1 | · | · | · | -2.8 | · | · | |
| P / FCF | · | -11.9 | · | · | · | -17.9 | · | · | · | -1.8 | · | · | · | -2.6 | · | · | |
| EV / EBITDA | -7.0 | 24.8 | · | 11.5 | 464.4 | 10.4 | · | 15.0 | -7.7 | 21.0 | · | -5.6 | -5.6 | -21.5 | · | -44.8 | |
| EV / FCF | · | -23.3 | · | · | · | -52.8 | · | · | · | -19.3 | · | · | · | -12.3 | · | · | |
| EV / Revenue | 1.1 | 1.1 | · | 1.0 | 0.8 | 0.7 | · | 0.9 | 1.3 | 1.3 | · | 1.2 | 1.5 | 2.5 | · | 1.2 | |
| Earnings Yield | -32.6% | 23.5% | · | 44.7% | -36.8% | -40.3% | · | -98.6% | -226.5% | -544.7% | · | -449.7% | -162.7% | -75.9% | · | 3.3% |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-09-30 | |
|---|---|---|---|---|---|
| Revenu | $743M | $1.04B | $1.05B | $1.12B | — |
| Marge Brute % | — | — | 30.3% | 34.3% | — |
| Marge d'exploitation % | 13.5% | -10.4% | -69.2% | -15.2% | — |
| Résultat net | $53M | $-191M | $-760M | $-212M | — |
| BPA dilué | $0.93 | $-3.60 | $-14.85 | $-4.22 | — |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-09-30 | |
|---|---|---|---|---|---|
| Dette / Capitaux propres | 1.1 | 1.4 | 2.0 | — | — |
| Ratio de liquidité | 5.0 | 3.7 | 1.0 | — | — |
| Ratio de liquidité réduite | 2.2 | 1.6 | 0.5 | — | — |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-09-30 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $157M | $36M | $-258M | $-150M | — |
Dernières actualités Actualités récentes mentionnant cette entreprise
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 212 déclarants · $262.9M total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 36 (+2 vs T. préc.) | 24 (+2 vs T. préc.) | 65 (+2 vs T. préc.) | 61 (+6 vs T. préc.) | +3.8M |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| DIMENSIONAL FUND ADVISORS LP | $24 599 540 | 2 935 506 | 9,36% | Actions |
| STATE STREET CORP | $24 556 367 | 2 929 238 | 9,34% | Actions |
| AMERICAN CENTURY COMPANIES INC | $23 216 354 | 2 770 448 | 8,83% | Actions |
| VANGUARD CAPITAL MANAGEMENT LLC | $18 426 271 | 2 198 839 | 7,01% | Actions |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $10 062 629 | 1 200 791 | 3,83% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $9 567 235 | 1 141 339 | 3,64% | Actions |
| OAK HILL ADVISORS LP | $9 329 772 | 1 113 338 | 3,55% | Actions |
| MILLENNIUM MANAGEMENT LLC | $8 984 910 | 1 072 185 | 3,42% | Actions |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $8 626 129 | 1 029 371 | 3,28% | Actions |
| Prescott Group Capital Management, L.L.C. | $6 475 821 | 772 771 | 2,46% | Actions |
| RENAISSANCE TECHNOLOGIES LLC | $5 725 610 | 683 247 | 2,18% | Actions |
| PRUDENTIAL FINANCIAL INC | $5 719 308 | 682 495 | 2,18% | Actions |
| D. E. Shaw & Co., Inc. | $5 572 440 | 664 969 | 2,12% | Actions |
| GOLDMAN SACHS GROUP INC | $4 591 829 | 547 951 | 1,75% | Actions |
| Allianz Asset Management GmbH | $4 556 885 | 543 781 | 1,73% | Actions |
| PALISADE CAPITAL MANAGEMENT, LP | $4 316 191 | 515 059 | 1,64% | Actions |
| NEW YORK STATE COMMON RETIREMENT FUND | $4 306 516 | 513 904 | 1,64% | Actions |
| TWO SIGMA INVESTMENTS, LP | $4 091 820 | 488 284 | 1,56% | Actions |
| VANGUARD GROUP INC | $4 091 457 | 331 024 | 1,56% | Actions |
| Prosight Management, LP | $3 854 398 | 459 952 | 1,47% | Actions |
| Trexquant Investment LP | $3 753 050 | 447 858 | 1,43% | Actions |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $3 690 745 | 440 423 | 1,40% | Actions |
| Connor, Clark & Lunn Investment Management Ltd. | $2 966 378 | 353 983 | 1,13% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $2 863 614 | 341 720 | 1,09% | Actions |
| PANAGORA ASSET MANAGEMENT INC | $2 757 523 | 329 060 | 1,05% | Actions |
| Values First Advisors, Inc. | $2 526 468 | 301 488 | 0,96% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2 420 144 | 288 800 | 0,92% | Option d'achat |
| GLOBEFLEX CAPITAL L P | $2 022 077 | 241 298 | 0,77% | Actions |
| FMR LLC | $1 790 865 | 213 707 | 0,68% | Actions |
| Brandywine Global Investment Management, LLC | $1 610 632 | 130 310 | 0,61% | Actions |
| DEUTSCHE BANK AG\ | $1 591 513 | 189 918 | 0,61% | Actions |
| Morse Asset Management, Inc | $1 536 339 | 183 334 | 0,58% | Actions |
| WOLVERINE ASSET MANAGEMENT LLC | $1 465 939 | 174 933 | 0,56% | Actions |
| Y-Intercept (Hong Kong) Ltd | $1 390 066 | 165 879 | 0,53% | Actions |
| ARISTEIA CAPITAL, L.L.C. | $1 355 490 | 161 753 | 0,52% | Actions |
| Squarepoint Ops LLC | $1 240 374 | 148 016 | 0,47% | Actions |
| CREDIT AGRICOLE S A | $1 225 994 | 146 300 | 0,47% | Actions |
| FRANKLIN RESOURCES INC | $1 140 518 | 136 100 | 0,43% | Actions |
| Bank of New York Mellon Corp | $1 107 082 | 132 110 | 0,42% | Actions |
| BANK OF AMERICA CORP /DE/ | $1 038 232 | 123 894 | 0,39% | Actions |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $1 028 000 | 122 700 | 0,39% | Actions |
| FULLER & THALER ASSET MANAGEMENT, INC. | $946 647 | 112 965 | 0,36% | Actions |
| SILVER OAK SECURITIES, INCORPORATED | $929 024 | 110 862 | 0,35% | Actions |
| CITADEL ADVISORS LLC | $850 570 | 101 500 | 0,32% | Option d'achat |
| Soviero Asset Management, LP | $838 000 | 100 000 | 0,32% | Actions |
| MACKENZIE FINANCIAL CORP | $817 151 | 97 512 | 0,31% | Actions |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $810 346 | 96 700 | 0,31% | Actions |
| Cetera Investment Advisers | $807 002 | 96 301 | 0,31% | Actions |
| UBS Group AG | $801 765 | 95 676 | 0,31% | Actions |
| SEGALL BRYANT & HAMILL, LLC | $797 818 | 95 205 | 0,30% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $785 206 | 93 700 | 0,30% | Option de vente |
| Sanctuary Advisors, LLC | $746 800 | 89 117 | 0,28% | Actions |
| MORGAN STANLEY | $734 281 | 87 623 | 0,28% | Actions |
| MARTINGALE ASSET MANAGEMENT L P | $656 205 | 78 306 | 0,25% | Actions |
| EVOLVE PRIVATE WEALTH, LLC | $592 801 | 70 740 | 0,23% | Actions |
| TWO SIGMA ADVISERS, LP | $561 144 | 45 400 | 0,21% | Actions |
| RHUMBLINE ADVISERS | $560 997 | 66 946 | 0,21% | Actions |
| Man Group plc | $557 496 | 66 527 | 0,21% | Actions |
| JANE STREET GROUP, LLC | $552 242 | 65 900 | 0,21% | Option d'achat |
| LPL Financial LLC | $543 828 | 64 896 | 0,21% | Actions |
| ALLIANCEBERNSTEIN L.P. | $539 334 | 64 980 | 0,21% | Actions |
| Susquehanna Portfolio Strategies, LLC | $529 624 | 63 201 | 0,20% | Actions |
| CITIGROUP INC | $527 219 | 62 914 | 0,20% | Actions |
| JAMES INVESTMENT RESEARCH, INC. | $519 250 | 61 963 | 0,20% | Actions |
| CITADEL ADVISORS LLC | $506 990 | 60 500 | 0,19% | Option de vente |
| Palumbo Wealth Management LLC | $490 557 | 58 539 | 0,19% | Actions |
| IEQ CAPITAL, LLC | $488 152 | 58 252 | 0,19% | Actions |
| Assenagon Asset Management S.A. | $473 093 | 56 455 | 0,18% | Actions |
| Mariner, LLC | $467 769 | 55 817 | 0,18% | Actions |
| FEDERATED HERMES, INC. | $461 621 | 55 086 | 0,18% | Actions |
| WELLINGTON MANAGEMENT GROUP LLP | $416 939 | 49 754 | 0,16% | Actions |
| Vanguard Global Advisers, LLC | $407 888 | 48 674 | 0,16% | Actions |
| Advantage Alpha Capital Partners LP | $405 156 | 45 936 | 0,15% | Actions |
| Rafferty Asset Management, LLC | $397 463 | 47 430 | 0,15% | Actions |
| WINTON GROUP Ltd | $383 335 | 45 744 | 0,15% | Actions |
| Quantinno Capital Management LP | $375 784 | 44 843 | 0,14% | Actions |
| ExodusPoint Capital Management, LP | $367 731 | 43 882 | 0,14% | Actions |
| TRUIST FINANCIAL CORP | $365 966 | 43 671 | 0,14% | Actions |
| WOLVERINE TRADING, LLC | $353 130 | 39 500 | 0,13% | Option de vente |
| Brevan Howard Capital Management LP | $326 116 | 38 916 | 0,12% | Actions |
| Integrated Quantitative Investments LLC | $322 638 | 38 501 | 0,12% | Actions |
| CANADA PENSION PLAN INVESTMENT BOARD | $292 462 | 34 900 | 0,11% | Actions |
| Cambria Investment Management, L.P. | $285 247 | 34 039 | 0,11% | Actions |
| CWM, LLC | $280 017 | 33 737 | 0,11% | Actions |
| ENVESTNET ASSET MANAGEMENT INC | $278 392 | 33 221 | 0,11% | Actions |
| WOLVERINE TRADING, LLC | $272 670 | 30 500 | 0,10% | Option d'achat |
| OPPENHEIMER ASSET MANAGEMENT INC. | $265 202 | 31 647 | 0,10% | Actions |
| MetLife Investment Management, LLC | $250 839 | 29 933 | 0,10% | Actions |
| Keystone Financial Group | $238 730 | 28 488 | 0,09% | Actions |
| BANK OF MONTREAL /CAN/ | $229 847 | 27 428 | 0,09% | Actions |
| BlackRock, Inc. | $225 045 | 26 855 | 0,09% | Actions |
| MERCER GLOBAL ADVISORS INC /ADV | $221 391 | 26 419 | 0,08% | Actions |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $216 237 | 25 804 | 0,08% | Actions |
| WOLVERINE TRADING, LLC | $208 928 | 23 370 | 0,08% | Actions |
| State of Wyoming | $203 408 | 24 273 | 0,08% | Actions |
| PROFUND ADVISORS LLC | $202 360 | 24 148 | 0,08% | Actions |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $198 054 | 24 603 | 0,08% | Actions |
| Glenmede Investment Management, LP | $183 438 | 20 798 | 0,07% | Actions |
| Graham Capital Management, L.P. | $180 941 | 21 592 | 0,07% | Actions |
| DIVERSIFIED TRUST CO | $173 625 | 20 719 | 0,07% | Actions |
Initiés de la société 47 initiés · 10 dirigeants · 5 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Daniel Abdun-Nabi | Chief Executive Officer | 5 juin 2018 S | 197 343 | 0 | 0 | $0 |
| Richard S Lindahl | EVP, Chief Financial Officer | 8 juin 2026 F | 374 083 | 0 | 0 | $0 |
| Don R Elsey | Chief Financial Officer | 13 mars 2012 A | 26 614 | 0 | 0 | $0 |
| Paul Anthony Williams | SVP, Products Business | 1 juillet 2026 S | 159 098 | 0 | 1 | $-25 200 |
| William Hartzel | SVP, Bioservices | 8 juin 2026 F | 185 558 | 0 | 0 | $0 |
| Coleen Glessner | EVP, Quality & Ethics, and CPL | 8 juin 2026 F | 202 201 | 0 | 0 | $0 |
| Barry Labinger | EVP, Biosciences Div. | 13 novembre 2015 S | 25 182 | 0 | 0 | $0 |
| Steven Chatfield | EVP, BioSciences | 14 mars 2013 F | 28 000 | 0 | 0 | $0 |
| Kyle Keese | EVP, BioSciences Division | 15 mars 2011 A | 18 759 | 0 | 0 | $0 |
| Stephen Lockhart | SVP Product Development | 11 novembre 2010 M | 6 980 | 0 | 0 | $0 |
| John D Fowler JR | Administrateur | 30 avril 2026 A | 30 350 | 0 | 0 | $0 |
| Fuad El-Hibri | Administrateur | 3 décembre 2021 J | 206 434 | 0 | 0 | $0 |
| John Niederhuber | Administrateur | 18 mai 2016 D | 30 300 | 0 | 0 | $0 |
| Shahzad Malik | Administrateur | 14 juin 2007 A | — | 0 | 0 | $0 |
| Intervac, L.L.C. | Détenteur de 10% | 18 septembre 2012 J | 4 344 250 | 0 | 0 | $0 |
| BioPharm, L.L.C. | Détenteur de 10% | 27 mai 2010 J | 2 265 043 | 0 | 0 | $0 |
| Microscience Investments LTD | Détenteur de 10% | 8 mars 2007 J | 0 | 0 | 0 | $0 |
| Zsolt Harsanyi | — | 30 avril 2026 A | 149 076 | 0 | 0 | $0 |
| Ronald Richard | — | 30 avril 2026 A | 123 761 | 0 | 2 | $-263 101 |
| Keith Katkin | — | 30 avril 2026 A | 96 294 | 0 | 1 | $-128 183 |
| Joseph C Papa | — | 29 avril 2026 A | 493 153 | 0 | 0 | $0 |
| Kathryn C Zoon | — | 30 avril 2025 A | 78 885 | 0 | 0 | $0 |
| Donald W Degolyer | — | 30 avril 2025 A | 145 503 | 0 | 0 | $0 |
| Sujata Tyagi Dayal | — | 30 avril 2025 A | 97 532 | 0 | 0 | $0 |
| Neal Franklin Fowler | — | 30 avril 2025 A | 135 503 | 0 | 0 | $0 |
| Marvin L White | — | 30 avril 2025 A | 88 495 | 0 | 0 | $0 |
| Louis W Sullivan | — | 30 avril 2025 A | 139 098 | 0 | 0 | $0 |
| Simon C Lowry | — | 6 mars 2025 A | 91 982 | 0 | 0 | $0 |
| Jessica Perl | — | 6 mars 2025 A | 68 387 | 0 | 0 | $0 |
| Jennifer Lynne Fox | — | 11 juillet 2024 A | 186 382 | 0 | 0 | $0 |
| Adam Havey | — | 9 juin 2023 A | 174 398 | 0 | 0 | $0 |
| Robert Kramer | — | 9 juin 2023 A | 506 059 | 0 | 0 | $0 |
| Jerome M Hauer | — | 25 mai 2023 A | 57 508 | 0 | 0 | $0 |
| Katherine Strei | — | 28 février 2023 F | 62 824 | 0 | 0 | $0 |
| Atul Saran | — | 28 février 2023 F | 86 645 | 0 | 0 | $0 |
| George A Joulwan | — | 26 mai 2022 A | 40 244 | 0 | 0 | $0 |
| Karen L. Smith | — | 7 mai 2021 F | 11 888 | 0 | 0 | $0 |
| Sean Kirk | — | 31 mars 2021 F | 17 776 | 0 | 0 | $0 |
| Sue Bailey | — | 4 mars 2021 S | 24 427 | 0 | 0 | $0 |
| Denise Esposito | — | 10 mars 2009 A | 500 | 0 | 0 | $0 |
| Biologika, L.L.C. | — | 4 juin 2008 S | 1 399 764 | 0 | 0 | $0 |
| Joe M Allbaugh | — | 21 mai 2008 A | — | 0 | 0 | $0 |
| Michigan Biologic Products, Inc. | — | 28 mars 2008 S | 1 269 390 | 0 | 0 | $0 |
| Mauro Gibellini | — | 4 juin 2007 S | 0 | 0 | 0 | $0 |
| Thomas Zink | — | 17 mai 2007 P | 1 000 | 0 | 0 | $0 |
| Edward Arcuri | — | 8 mai 2007 M | 76 722 | 0 | 0 | $0 |
| Robert Calvin Myers | — | 20 novembre 2006 C | — | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Activistes et détenteurs de 5%+ 1 participation
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| Emergent BioSolutions Inc. | 23 août 2010 | — | Dépôt initial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Détention d'ETF Détenu par 78 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| EWO · iShares, Inc. | 24,34% | 347 883 SH | 8 août 2026 | Quotidien |
| EUFN · iShares Trust | 1,16% | 352 361 SH | 8 août 2026 | Quotidien |
| MTRA · Invesco Actively Managed Exchange-T… | 1,12% | 11 534 SH | 8 août 2026 | Quotidien |
| PIZ · Invesco Exchange-Traded Fund Trust … | 0,69% | 35 928 SH | 8 août 2026 | Quotidien |
| IDMO · Invesco Exchange-Traded Fund Trust … | 0,66% | 201 926 SH | 8 août 2026 | Quotidien |
| EZU · iShares, Inc. | 0,54% | 381 737 SH | 8 août 2026 | Quotidien |
| DMXF · iShares Trust | 0,39% | 26 552 SH | 8 août 2026 | Quotidien |
| BSJS · Invesco Exchange-Traded Self-Indexe… | 0,35% | 2 821 000 | 8 août 2026 | Quotidien |
| IEV · iShares Trust | 0,31% | 37 421 SH | 8 août 2026 | Quotidien |
| IVLU · iShares Trust | 0,31% | 99 461 SH | 8 août 2026 | Quotidien |
| IMTM · iShares Trust | 0,30% | 91 595 SH | 8 août 2026 | Quotidien |
| IXG · iShares Trust | 0,28% | 13 907 SH | 8 août 2026 | Quotidien |
| IEUR · iShares Trust | 0,26% | 171 214 SH | 8 août 2026 | Quotidien |
| VGK · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,24% | 673 051 SH | 8 août 2026 | Quotidien |
| PABD · iShares Trust | 0,22% | 5 313 SH | 8 août 2026 | Quotidien |
| VYMI · VANGUARD WHITEHALL FUNDS | 0,20% | 312 634 SH | 8 août 2026 | Quotidien |
| EFG · iShares Trust | 0,20% | 236 854 SH | 8 août 2026 | Quotidien |
| EFV · iShares Trust | 0,19% | 412 501 SH | 8 août 2026 | Quotidien |
| EFA · iShares Trust | 0,19% | 1 084 946 SH | 8 août 2026 | Quotidien |
| FSCC · Federated Hermes ETF Trust | 0,17% | 51 825 NS | 31 mai 2026 | N-PORT |
| AFSM · First Trust Exchange-Traded Fund VI… | 0,17% | 18 243 NS | 31 mai 2026 | N-PORT |
| IEFA · iShares Trust | 0,17% | 2 281 517 SH | 8 août 2026 | Quotidien |
| ESGD · iShares Trust | 0,16% | 138 616 SH | 8 août 2026 | Quotidien |
| LABU · Direxion Shares ETF Trust | 0,15% | 91 705 NS | 30 avril 2026 | N-PORT |
| IDEV · iShares Trust | 0,15% | 333 751 SH | 8 août 2026 | Quotidien |
| ACWX · iShares Trust | 0,12% | 96 686 SH | 8 août 2026 | Quotidien |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0,11% | 2 737 509 SH | 8 août 2026 | Quotidien |
| VSGX · VANGUARD WORLD FUND | 0,11% | 56 354 SH | 8 août 2026 | Quotidien |
| PXF · Invesco Exchange-Traded Fund Trust … | 0,11% | 22 740 SH | 8 août 2026 | Quotidien |
| IXUS · iShares Trust | 0,10% | 423 874 SH | 8 août 2026 | Quotidien |
| CALF · Pacer Funds Trust | 0,10% | 412 173 NS | 30 avril 2026 | N-PORT |
| VEU · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,09% | 655 464 SH | 8 août 2026 | Quotidien |
| VXUS · VANGUARD STAR FUNDS | 0,08% | 4 120 164 SH | 8 août 2026 | Quotidien |
| FNDA · SCHWAB STRATEGIC TRUST | 0,08% | 757 640 NS | 31 mai 2026 | N-PORT |
| AVUV · AMERICAN CENTURY ETF TRUST | 0,08% | 2 270 234 NS | 31 mai 2026 | N-PORT |
| IWC · iShares Trust | 0,06% | 177 050 SH | 8 août 2026 | Quotidien |
| GSSC · Goldman Sachs ETF Trust | 0,06% | 67 946 NS | 31 mai 2026 | N-PORT |
| TOK · iShares Trust | 0,05% | 895 SH | 8 août 2026 | Quotidien |
| URTH · iShares, Inc. | 0,05% | 28 246 SH | 8 août 2026 | Quotidien |
| ACWI · iShares Trust | 0,04% | 100 105 SH | 8 août 2026 | Quotidien |
| SMLF · iShares Trust | 0,03% | 269 476 SH | 8 août 2026 | Quotidien |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,03% | 98 804 NS | 31 mai 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,03% | 283 798 NS | 30 avril 2026 | N-PORT |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,03% | 242 129 SH | 8 août 2026 | Quotidien |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,03% | 45 382 SH | 8 août 2026 | Quotidien |
| TMFX · RBB Fund, Inc. | 0,02% | 845 NS | 31 mai 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,02% | 372 675 NS | 30 avril 2026 | N-PORT |
| CRBN · iShares Trust | 0,02% | 1 830 SH | 8 août 2026 | Quotidien |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 118 597 SH | 8 août 2026 | Quotidien |
| IBB · iShares Trust | 0,02% | 355 059 SH | 8 août 2026 | Quotidien |